Monoclonal antibodies offer promise well beyond treating COVID-19: They’re a potential game changer in the fight against malaria, HIV, and other infectious diseases.
Fourteen research projects will focus on antiviral research and drug development for henipaviruses, a subgroup of viruses with pandemic potential COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/